Approval is based on data from the NIH-sponsored Phase III OUtMATCH study, which showed a significantly higher proportion of food allergy patients as young as 1 year treated with Xolair could tolerate small amounts
Stellantis and Ample Establish Partnership to Leverage Ample's Modular Battery Swapping Technology for Use in Stellantis Electric VehiclesInnovative battery swapping solution capable of delivering a fully charged battery